Papers
1
Total Citations
5
H-Index
1
About
Ragini Desai is a rising infectious disease researcher whose work bridges virology and clinical diagnostics, with a focus on pandemic preparedness and SARS-CoV-2 immunology. Her most cited study, "An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay" (2023), introduces a groundbreaking, safe, and scalable method for measuring neutralizing antibodies against SARS-CoV-2 and its variants of concern. By engineering a highly attenuated live virus (Δ3678_WA1-s), Desai's team enabled high-throughput serological monitoring in BSL-2 facilities—a critical advancement for low-resource settings and rapid variant surveillance. This work has already garnered 5 citations, reflecting its immediate utility in the global COVID-19 response. Desai's contributions extend beyond the bench: she has championed the integration of research and clinical workflows, accelerating the translation of lab discoveries into actionable public health tools. Her platform not only supports vaccine efficacy studies but also provides a template for future outbreak responses. As a researcher committed to open-access, reproducible science, Desai is shaping the next generation of serological assays—making her a key voice in emerging infectious disease preparedness.
Research Focus
Key Achievements
Top Papers
- 1